Pictet Asset Management
MRTX

Pictet Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Pictet Asset Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,184
Closed -$305K – 2043
2023
Q4 		$305K Sell
5,184
-1,758
-25% -$98.8K ﹤0.01% 1535
2023
Q3 		$302K Buy
+6,942
New +$248K ﹤0.01% 1466

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Pictet Asset Management's MRTX Position: Q1 2024 in Review

Pictet Asset Management sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 5,184 shares — an estimated $305K sold.

Pictet Asset Management first reported a position in MRTX in Q3 2023 and held it in 2 quarters. The position peaked at $305K in Q4 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Pictet Asset Management reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Pictet Asset Management sold 5,184 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $305K.
  • Pictet Asset Management first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
  • Pictet Asset Management's Mirati Therapeutics, Inc. Common Stock position peaked at $305K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Pictet Asset Management's 13F filing for Q1 2024, filed 14 May 2024.